Skip to content

CIRBA

Active
Private limited companyfounded 200520 yrs activeBorrensstraat 51, 1050 Elsene, BelgiumKBO/BCE: BE 0877.341.838
Summary

CIRBA has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14,096 and a net result of €7,505. Equity remains stable across the filed fiscal years (±0.7% per year). Its solvency ranks better than 34% of 12348 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€67,062total assets 2025
Equity
€14,096
Profit
€7,505
Financial health
67 Healthy Checked score 2025
Bankruptcy chance 12 m
0.8%
Structure
Accounts filed 49 d late0 of 6 deeds read
Why 67- Latest accounts 49 days late; 3 of the last 3 late- Equity €14,096 (21.0% of total assets)+ Founded in 2005Show the evidence

Checked score

Score 2025
67 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 27% of its sector peers (NACE 46, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Average
Solvency 46-20
equity 21.0% of total assets
Liquidity 23+2
short-term debt 79.0% · cash 13.3%
Profitability 65-14
return on assets 11.2%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,765 companies)
Last 11 months 12-2025: 1.1% 01-2026: 1.0%▼ -1.6% vs 12-2025 02-2026: 1.0%● 0.0% vs 01-2026 03-2026: 1.0%▼ -1.5% vs 02-2026 04-2026: 1.0%▲ +0.5% vs 03-2026 05-2026: 1.0%▼ -2.1% vs 04-2026 06-2026: 1.0%▼ -2.3% vs 05-2026 07-2026: 1.0%▲ +3.1% vs 06-2026 08-2026: 1.6%▲ +57.8% vs 07-2026 09-2026: 1.7%▲ +9.5% vs 08-2026highest value 10-2026: 0.8%▼ -55.6% vs 09-2026lowest value
  • Latest accounts 49 days late; 3 of the last 3 late raises the probability
  • Founded in 2005 lowers the probability for this profile
  • Equity €14,096 (21.0% of total assets) raises the probability
Credit up to €500 at 30 days acceptable
Liquidity tight (current ratio 1.27 against 1.16 in 2024; short-term debt: 79% and cash: 13.3% of total assets), and 79% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, micro). Better than this share of them on solvency 32%, liquidity 22%, profitability 48%, growth against the median 8%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Latest accounts 49 days late; 3 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
lowers risk · Founded in 2005
In the bankruptcy model this factor lowers the probability for this profile.
KBO
raises risk · Equity €14,096 (21.0% of total assets)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-09-2026, 49 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
49 d late
2024
47 d late
2023
62 d late
2022
52 d late
2021
75 d late
2020
61 d late
2019
106 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 65 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 21 September (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Highest result since 2018net €7,505 ▲6.9%
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Total assets 20256 fiscal years filed €67,062 View
  • Active since 2005founded 18-11-2005 20 years View

By topic

Financials

Fiscal year
2025
Total assets
€67,062
Profit
€7,505
Solvency
21.0%
Total assets▼ 22.0%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-07-2027
  1. 18-09-2026Annual accounts filed
  2. 31-12-2025Highest result since 2018
  3. 16-09-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
18-11-2005
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.